Annual Total Expenses
$314.59 M
-$21.11 M-6.29%
31 December 2023
Summary:
Allogene Therapeutics annual total expenses is currently $314.59 million, with the most recent change of -$21.11 million (-6.29%) on 31 December 2023. During the last 3 years, it has risen by +$56.34 million (+21.82%). ALLO annual total expenses is now -6.29% below its all-time high of $335.69 million, reached on 31 December 2022.ALLO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$61.05 M
-$5.40 M-8.12%
30 September 2024
Summary:
Allogene Therapeutics quarterly total expenses is currently $61.05 million, with the most recent change of -$5.40 million (-8.12%) on 30 September 2024. Over the past year, it has dropped by -$1.97 million (-3.13%). ALLO quarterly total expenses is now -54.78% below its all-time high of $135.01 million, reached on 30 June 2018.ALLO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.3% | -3.1% |
| 3 y3 years | +21.8% | -21.4% |
| 5 y5 years | +63.1% | +11.0% |
ALLO Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.3% | +21.8% | -38.4% | at low |
| 5 y | 5 years | -6.3% | +63.1% | -38.4% | +11.0% |
| alltime | all time | -6.3% | +63.1% | -54.8% | +2250.6% |
Allogene Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $61.05 M(-8.1%) |
| June 2024 | - | $66.44 M(-4.4%) |
| Mar 2024 | - | $69.53 M(-3.3%) |
| Dec 2023 | $314.59 M(-6.3%) | $71.89 M(+14.1%) |
| Sept 2023 | - | $63.02 M(-21.8%) |
| June 2023 | - | $80.56 M(-18.7%) |
| Mar 2023 | - | $99.12 M(+2.8%) |
| Dec 2022 | $335.69 M(+14.1%) | $96.42 M(+16.8%) |
| Sept 2022 | - | $82.54 M(+7.6%) |
| June 2022 | - | $76.68 M(-4.2%) |
| Mar 2022 | - | $80.05 M(+8.3%) |
| Dec 2021 | $294.28 M | $73.94 M(-4.9%) |
| Sept 2021 | - | $77.72 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $71.07 M(-0.7%) |
| Mar 2021 | - | $71.55 M(+3.1%) |
| Dec 2020 | $258.24 M(+27.8%) | $69.36 M(+1.9%) |
| Sept 2020 | - | $68.04 M(+7.7%) |
| June 2020 | - | $63.16 M(+9.5%) |
| Mar 2020 | - | $57.68 M(-10.7%) |
| Dec 2019 | $202.01 M(+4.8%) | $64.58 M(+17.4%) |
| Sept 2019 | - | $55.01 M(+19.7%) |
| June 2019 | - | $45.96 M(+26.1%) |
| Mar 2019 | - | $36.46 M(+10.3%) |
| Dec 2018 | $192.84 M | $33.05 M(+48.9%) |
| Sept 2018 | - | $22.19 M(-83.6%) |
| June 2018 | - | $135.01 M(+5098.8%) |
| Mar 2018 | - | $2.60 M |
FAQ
- What is Allogene Therapeutics annual total expenses?
- What is the all time high annual total expenses for Allogene Therapeutics?
- What is Allogene Therapeutics annual total expenses year-on-year change?
- What is Allogene Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly total expenses year-on-year change?
What is Allogene Therapeutics annual total expenses?
The current annual total expenses of ALLO is $314.59 M
What is the all time high annual total expenses for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total expenses is $335.69 M
What is Allogene Therapeutics annual total expenses year-on-year change?
Over the past year, ALLO annual total expenses has changed by -$21.11 M (-6.29%)
What is Allogene Therapeutics quarterly total expenses?
The current quarterly total expenses of ALLO is $61.05 M
What is the all time high quarterly total expenses for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total expenses is $135.01 M
What is Allogene Therapeutics quarterly total expenses year-on-year change?
Over the past year, ALLO quarterly total expenses has changed by -$1.97 M (-3.13%)